MANILA, Philippines — Takeda Healthcare Philippines on Thursday said that its voluntary withdrawal of its dengue applications in the US and Singapore has something to do with requested data collection. Takeda, a Japanese pharmaceutical company, is the manufacturer of the dengue vaccine called Qdenga (TAK-003) and has already applied for a certificate of product registration
About admin
